3043.0: Monday, November 13, 2000: 12:30 PM-2:00 PM | ||||
| ||||
| See individual abstracts for presenting author's disclosure statement. | ||||
| Learning Objectives: Refer to the individual abstracts for learning objectives | ||||
| Lynette Bradley, RPh,, PhD | ||||
| Analysis of the continued use of beta-blockers by an insured population after acute myocardial infarction Michael Hetzel, Kevin Hawkins, PhD, Vicki Wilson, MA, Connie Blachut, MPH, David Share, MD, Beth Goldman, MD | ||||
| Angiotensin converting enzyme inhibitor use in an heavily insured population of heart failure patients James J Sloan, MA, Mary Martus, RN, Frederick Fedorowicz, PA-C, Beth Goldman, MD, David Share, MD, Connie Blachut, MPH, Vicki Wilson, MA, Kevin Hawkins, PhD | ||||
| Combating inappropriate antibiotic use in a heavily insured population Frederick Fedorowicz, PA-C, David Share, MD, MPH, Asha Aggarwal, MPH, Vicki Wilson, MA, Susan Rubin, Connie Blachut, MPH, Beth Goldman, MD, MPH | ||||
| Doctors at Drug Risk: Implications for Clinical Practice and Cost Helene Levens Lipton, PhD, Angela D. Kuo, Samantha M. Collins | ||||
| Patient compliance in a structured pharmaceutical (clinical) care approach to the management of ambulatory patients with hyperlipidemia Pamala J Reed, DrPH, MPH, Richard Herrier, PharmD, Greta A Gourley, PhD, PharmD, Dick R Gourley, PharmD, David K Solomon, PharmD, Ed Armstrong, J. Lyle Bootman, PhD, James C Holt, PharmD, George Bass, PhD, Kenneth Kellick, PharmD, Kamala McMillan, PharmD, MS, Tracy Portner, PhD | ||||
| Prescription drug coverage for Medicare beneficiaries: what are states doing to fill the gaps? Kathryn E. Linehan, MPH, John Hansen, MBA | ||||
| Sponsor: | Medical Care | |||
| Cosponsors: | Health Administration | |||